← Every applicant
Orient Pharma FDA Approvals
2 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| TOFACITINIB CITRATENew drugJun 9, 2026TABLET, EXTENDED RELEASE, ORAL |
| EZETIMIBENew drugSep 13, 2022TABLET, ORAL |